New terminology for cytoreduction in advanced ovarian cancer

The Lancet Oncology

Volumn 12, Issue 3, 2011, Pages 214-

  Zapardiel, Ignacio ^a   Morrow, C Paul ^b  

^a HOSPITAL UNIVERSITARIO SANTA CRISTINA   (Spain)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CYTOREDUCTIVE SURGERY; HUMAN; LETTER; MINIMAL RESIDUAL DISEASE; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS;

FEMALE; HUMANS; OVARIAN NEOPLASMS; TERMINOLOGY AS TOPIC;

EID: 79952022586     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(10)70292-8     Document Type: Letter

References (5)

1. Shih KK, Chi DS Maximal cytoreductive effort in epithelial ovarian cancer surgery. J Gynecol Oncol 2010, 21:75-80.
2. Hacker NF, Berek JS, Lagasse LD, Nieberg RK, Elashoff RM Primary cytoreductive surgery for epithelial ovarian cancer. Obstet Gynecol 1983, 61:413-420.
3. Hoskins WJ Epithelial ovarian carcinoma: principles of primary surgery. Gynecol Oncol 1994, 55:S91-S96.
4. Bristow RE, Montz FJ, Lagasse LD, Leuchter RS, Karlan BY Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Gynecol Oncol 1999, 72:278-287.
5. Chi DS, Eisenhauer EL, Lang J, et al. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?. Gynecol Oncol 2006, 103:559-564.